Reassessing the Safety of Varenicline

被引：14

作者：

Evins, A. Eden ^{[1
,2
]}

机构：

[1] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA

[2] Massachusetts Gen Hosp, Ctr Addict Med, Boston, MA 02114 USA

来源：

AMERICAN JOURNAL OF PSYCHIATRY | 2013年 / 170卷 / 12期

关键词：

SMOKING-CESSATION; SCHIZOPHRENIA;

D O I：

10.1176/appi.ajp.2013.13091257

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

[No abstract available]

引用

页码：1385 / 1387

页数：3

共 10 条

[1]

[Anonymous], TREATING TOBACCO USE

[2] Effects of Varenicline on Smoking Cessation in Adults With Stably Treated Current or Past Major Depression [J].

Anthenelli, Robert M. ;

Morris, Chad ;

Ramey, Tanya S. ;

Dubrava, Sarah J. ;

Tsilkos, Kostas ;

Russ, Cristina ;

Yunis, Carla .

ANNALS OF INTERNAL MEDICINE, 2013, 159 (06) :390-+

[3] Population-Attributable Fractions of Axis I and Axis II Mental Disorders for Suicide Attempts: Findings From a Representative Sample of the Adult, Noninstitutionalized US Population [J].

Bolton, James M. ;

Robinson, Jennifer .

AMERICAN JOURNAL OF PUBLIC HEALTH, 2010, 100 (12) :2473-2480

[4] Varenicline, Smoking Cessation, and Neuropsychiatric Adverse Events [J].

Gibbons, Robert D. ;

Mann, J. John .

AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (12) :1460-1467

[5] Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database [J].

Gunnell, D. ;

Irvine, D. ;

Wise, L. ;

Davies, C. ;

Martin, R. M. .

BRITISH MEDICAL JOURNAL, 2009, 339 :1072

[6] Effects of Moderate-Dose Treatment With Varenicline on Neurobiological and Cognitive Biomarkers in Smokers and Nonsmokers With Schizophrenia or Schizoaffective Disorder [J].

Hong, L. Elliot ;

Thaker, Gunvant K. ;

McMahon, Robert P. ;

Summerfelt, Ann ;

RachBeisel, Jill ;

Fuller, Rebecca L. ;

Wonodi, Ikwunga ;

Buchanan, Robert W. ;

Myers, Carol ;

Heishman, Stephen J. ;

Yang, Jeff ;

Nye, Adrienne .

ARCHIVES OF GENERAL PSYCHIATRY, 2011, 68 (12) :1195-1206

[7] Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week Open-Label Trial [J].

Pachas, Gladys N. ;

Cather, Corinne ;

Pratt, Sarah I. ;

Hoeppner, Bettina ;

Nino, Johanna ;

Carlini, Sara V. ;

Achtyes, Eric D. ;

Lando, Harry ;

Mueser, Kim T. ;

Rigotti, Nancy A. ;

Goff, Donald C. ;

Evins, A. Eden .

JOURNAL OF DUAL DIAGNOSIS, 2012, 8 (02) :117-125

[8] Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial [J].

Shim, Joo-Cheol ;

Jung, Do-Un ;

Jung, Sung-Soo ;

Seo, Young-Soo ;

Cho, Deuk-Man ;

Lee, Ji-Heon ;

Lee, Sae-Woom ;

Kong, Bo-Geum ;

Kang, Je-Wook ;

Oh, Min-Kyung ;

Kim, Sang-Duk ;

McMahon, Robert P. ;

Kelly, Deanna L. .

NEUROPSYCHOPHARMACOLOGY, 2012, 37 (03) :660-668

[9] Interventions for smoking cessation and reduction in individuals with schizophrenia [J].

Tsoi, Daniel T. ;

Porwal, Mamta ;

CWebster, Angela .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (02)

[10] Smoking cessation interventions for smokers with current or past depression [J].

van der Meer, Regina M. ;

Willemsen, Marc C. ;

Smit, Filip ;

Cuijpers, Pim .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (08)

← 1 →